MAY 07, 2019 2:53 PM PDT

Siblings lead Researchers to Discover New Immunodeficiency Disease

WRITTEN BY: Tiffany Dazet

An infant was suffering from inflammatory bowel disease, eczema, food allergies, lung disease, and persistent cytomegalovirus (CMV) infection. His older sister was experiencing similar problems. The scientific investigation of their cases led researchers from the University of Colorado Anschutz Medical Campus to discover a new immunodeficiency disease that is caused by a single genetic mutation. Their findings were published last week in The Journal of Experimental Medicine.

The siblings’ symptoms were consistent with an immune dysregulation syndrome, which can lead to an increased cancer risk. Upon closer examination, researchers discovered a defect in a gene called IL2RB (encoding interleukin-2 receptor beta, IL-2R?), which causes a decrease in the number of immune cells (regulatory T cells) that prevent autoimmunity. These two children are the first known humans to have this genetic defect. 

Image via JEM

In addition to a decreased number of regulatory T cells, the siblings also had an accumulation of “natural killer” cells. When functioning correctly, natural killer cells protect against viral infections and cancer. However, in a press release from the University of Colorado medical campus, co-author Elena Hsieh, MD explains that “the mutation meant that the natural killer cells were incapable of maturing properly and could not clear CMV, resulting in persistent and debilitating infection.”

Hsieh emphasizes the rarity of tracking down a disease to a single gene; especially since there were not any documented cases of mutations in this gene that can lead to human disease. Co-author Cullen Dutmer, MD believes that others may likely suffer from this condition, but it hasn’t been identified. In the press release he states that “although clearly a rare disease, it has likely been missed in other children. Now that it is out there, we know to look for it.”

Researchers are hopeful that this genetic defect can be treated with gene therapy. Co-author Ross Kedl, Ph.D., suggests that “we could feasibly go in, manipulate the gene, and get it back in the right sequence.” Gene therapy is becoming a more viable treatment option with recent advances in identifying genetic causes of immunodeficiency diseases. Dutmer and Hsieh are hopeful that once a genetic cause is identified “that would allow for therapeutic interventions that are uniquely tailored to meet the need of the individuals.”

Sources: Journal of Experimental Medicine, CU Anschutz Today, Science Daily
 

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
OCT 01, 2020
Cardiology
Investigating Inflammation in Coronary Artery Bypass Grafts
OCT 01, 2020
Investigating Inflammation in Coronary Artery Bypass Grafts
The heart is a vital part of the body that can last one hundred years, yet even a small change can cause massive consequ ...
OCT 05, 2020
Microbiology
Deadly Microbe Linked to Childhood Brain Disorder
OCT 05, 2020
Deadly Microbe Linked to Childhood Brain Disorder
Pediatric hydrocephalus - excessive fluid on the brain of a child - has been connected to a bacterial pathogen.
OCT 07, 2020
Neuroscience
Researchers Discover Molecular Mechanism for Memory Formation
OCT 07, 2020
Researchers Discover Molecular Mechanism for Memory Formation
Researchers from MIT have found that when the brain forms a new memory, neurons known as 'engram cells' encode t ...
OCT 18, 2020
Cardiology
Many Heart Disease Deaths Are Preventable With Diet Improvements
OCT 18, 2020
Many Heart Disease Deaths Are Preventable With Diet Improvements
New research has suggested that over two-thirds of heart disease cases around the world are preventable with improvement ...
OCT 26, 2020
Cancer
Investigating the Receptor Protein FPR1 in Brain Cancer
OCT 26, 2020
Investigating the Receptor Protein FPR1 in Brain Cancer
Amongst the more common targets for cancer therapies are cell surface receptors. These receptors are proteins – us ...
OCT 29, 2020
Clinical & Molecular DX
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
OCT 29, 2020
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
 
Loading Comments...